Philanthropist, investor, and entrepreneur, Jason Hope has donated half a million dollars to the SENS Research Foundation, an organization dedicated to anti-aging medicine and technology.
Recognizing growing scientific interest in research related to the treatment of age-related disease, Hope concludes that for medical science to advance, preventative treatment must become a point of focus.
“We all want to live longer, healthier lives,” Hope says. “To achieve this, we much change our approach to medicine. It’s not only about treating disease and the effects of aging, it’s about prevention.”
It is a widely accepted fact that the state of medicine, particularly in the west, is much more oriented toward treating diseases and medical conditions after symptoms have manifested. We eat heavily processed foods, inhabit contaminated environments, and shirk the advice of health experts all in the hope that doctors will repair the damage after dangerous conditions emerge.
More and more, people are turning to health solutions outside of mainstream medicine. The long-term effects of Internet-based folk remedies are yet to be seen. But the evidence is clear that people are losing their confidence in the medical community.
Jason Hope was born and raised in Arizona where he received his MSU and a degree in finance from the Arizona State University Carey School of Business. Through his work in business consulting, politics, and philanthropy, he has shown a dedication to a multi-faceted approach to changing the culture surrounding the way we treat aging and age-related health conditions.
The SENS Foundation became involved in anti-aging research in 2009 and quickly became an important name in the field. The foundation runs the “Strategies for Engineered Negligible Senescence Research program which was previously operated by the Methuselah Foundation.
The goal of the SENS Foundation is to “transform the way the world researches and treats age-related disease.” Their approach focuses on repairing living cells and extracellular material. This is in direct contrast with traditional geriatric medicine which is interested only in treating the conditions that arise from the breakdown of the system over time. SENS researchers believe that by addressing aging on the cellular level, the aging process and the degeneration associated with it will become curable.
Hope told reporter Marianne Haynes, “I’m invested in SENS because I believe in their work. I understand how essential it is to the advancement of medicine. SENS has the power to redefine the healthcare, pharmaceutical, and biotech industries completely.”